Literature DB >> 1342259

Cholesterol and heart disease in older persons and women. Review of an NHLBI workshop.

T A Manolio1, T A Pearson, N K Wenger, E Barrett-Connor, G H Payne, W R Harlan.   

Abstract

The value of serum total cholesterol measurement in predicting coronary heart disease (CHD) is well established in middle-aged men, but has been questioned in middle-aged women and older people of both sexes. To address this, the most recent follow-up data from 25 populations in 22 US and international cohort studies were presented and analyzed at a recent National Heart, Lung, and Blood Institute (NHLBI) workshop. Crude relative and absolute excess risks of fatal CHD were determined for individual studies and pooled across studies to determine pooled risk estimates. Serum total cholesterol and low-density-lipoprotein (LDL) cholesterol levels predicted fatal CHD in middle-aged (< 65 years) and older (> or = 65 years) men and women, though the strength and consistency of these relationships in older women were diminished. High-density-lipoprotein (HDL) cholesterol levels inversely predicted CHD in middle-aged men and women and in older women, but not in older men. Data for minority groups and for overseas populations were similar to those for white people in the United States. Relative risk estimates were generally lower for older than for middle-aged subjects, but absolute excess risk was greater. Older people and middle-aged women with elevated cholesterol levels are clearly at increased risk of coronary disease; whether this risk can be modified by dietary or drug therapy, and at what level intervention is appropriate, must not be determined.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1342259     DOI: 10.1016/1047-2797(92)90051-q

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  43 in total

Review 1.  Obesity, hypertension, and vascular disease.

Authors:  K M Sowers; J R Sowers
Journal:  Curr Hypertens Rep       Date:  1999 Apr-May       Impact factor: 5.369

Review 2.  Hormones and heart disease: what we thought, what we have learned, what we still need to know.

Authors:  Marian C Limacher
Journal:  Trans Am Clin Climatol Assoc       Date:  2002

3.  Short and long term association of a single serum cholesterol measurement in middle-aged men in prediction of fatal coronary and other cardiovascular events: a cross-cultural comparison through Europe.

Authors:  Alessandro Menotti; Mariapaola Lanti; Daan Kromhout; Anthony Kafatos; Srecko Nedeljkovic; Aulikki Nissinen
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

Review 4.  Cardiovascular drug therapy in the elderly: benefits and challenges.

Authors:  Jerome L Fleg; Wilbert S Aronow; William H Frishman
Journal:  Nat Rev Cardiol       Date:  2010-10-26       Impact factor: 32.419

Review 5.  Biomarkers related to aging in human populations.

Authors:  Eileen Crimmins; Sarinnapha Vasunilashorn; Jung Ki Kim; Dawn Alley
Journal:  Adv Clin Chem       Date:  2008       Impact factor: 5.394

6.  Coronary risk factors predicting early and late coronary deaths.

Authors:  A Menotti; M Lanti
Journal:  Heart       Date:  2003-01       Impact factor: 5.994

7.  Biodemography: new approaches to understanding trends and differences in population health and mortality.

Authors:  Eileen Crimmins; Jung Ki Kim; Sarinnapha Vasunilashorn
Journal:  Demography       Date:  2010

8.  Age-related changes in total and high-density-lipoprotein cholesterol in elderly Dutch men.

Authors:  M P Weijenberg; E J Feskens; D Kromhout
Journal:  Am J Public Health       Date:  1996-06       Impact factor: 9.308

Review 9.  Outcomes of lipid-lowering treatment in postmenopausal women.

Authors:  John C LaRosa
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

10.  Cardiovascular risk and all-cause mortality; a 12 year follow-up study in The Netherlands.

Authors:  A W Hoes; D E Grobbee; H A Valkenburg; J Lubsen; A Hofman
Journal:  Eur J Epidemiol       Date:  1993-05       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.